Tesla
Tesla Motors San Carlos, Calif.-based Tesla Motors designs and manufactures electric vehicles with exceptional design, performance and efficiency, while conforming to all North
American and European safety, environmental and durability standards. The Roadster, which has a 0-to-60 mph acceleration of 3.9 seconds and a base price of $101,500 after a federal tax credit, is the only highway-capable production EV for sale in North America and Europe. Tesla expects to begin Model S production in late 2011. Tesla is already taking orders for the sedan, which has an anticipated base price of $49,900 after the tax credit.
View Older Stories View More Recent Stories
-
Factbox-Elon Musk lays out Terafab AI chip project plan
-
Musk sounds cautious tone on robotaxis amid slower-than-expected rollout
-
Intel forecasts second-quarter revenue above estimates, shares jump 19%
-
Intel Reports First-Quarter 2026 Financial Results
-
Top 3 Cryptos to Buy Now: Pepeto Leads With $9.2M Raised and a Confirmed Listing While AVAX and XRP Test Key Levels
-
Morgan Stanley on Tesla (TSLA): investment cycle 'necessary' for leadership in autonomy, physical AI; confident in LT trajectory
-
Federal Judge Halts Trump Policies Blocking Wind and Solar Projects
-
Intel will report Q1 earnings today: What could it mean for INTC’s turnaround story
-
AINewsBreaks – American Fusion Inc. (OTC: AMFN) Positioned At Center Of AI-Driven Energy Demand Surge Alongside Major Industry Players
-
Roth/MKM on Tesla (TSLA): buyers on any weakness
-
Piper Sandler on Tesla (TSLA): 'Upsized Capex Outlook Offsets Otherwise Encouraging Q1'
-
Cantor Fitzgerald Reiterates Overweight Rating on Tesla (TSLA) Following Q1 Earnings and Revenue Beat
-
Analysts flag Capex and slower AI rollout as key risks for Tesla
-
Tesla (TSLA) PT Lowered to $475 at RBC Capital
-
Elektros Advances Lithium Supply Initiative Through Targeted Lithium Refinery Outreach
-
Tesla stock reverses course as capex hike offsets Q1 beat
-
Energy Constraints Emerging as Critical Factor in Sustaining AI Expansion
-
Tesla's $25 billion spending plan tests investor faith in unproven AI bets
-
Stifel on Tesla (TSLA): 'We believe 1Q26 results and commentary are about neutral for the shares'
-
Tesla (TSLA) PT Raised to $450 at Canaccord
-
Analysis-Biggest IPO wave in history promises $3 trillion in value – with no profits
-
Intel gains after Musk says Tesla's Terafab will use its 14A chipmaking process
-
Morning Bid: Tech checked as oil boils
-
Tesla (TSLA) PT Lowered to $522 at Baird
-
Tesla acquires AI hardware company for up to $2 billion in stock
-
Tesla: to buy AI hardware company for up to $2B in Tesla common stock and equity awards
-
Exclusive-SpaceX IPO filing shows Elon Musk can retain board control
-
Form 10-Q Tesla, Inc. For: Mar 31
-
Exclusive-SpaceX conquered the stars, now eyes bigger opportunity in AI
-
Oppenheimer on Tesla (TSLA): 'We expect this pivot to last at least three years if not longer'
-
Tesla to create 1,000 new jobs in Germany, responding to Model Y demand
-
Stocks close lower on fading hopes for quick Iran deal, mixed quarterly earnings
-
Tesla (TSLA) PT Lowered to $480 at Mizuho
-
Truist: 'TSLA's transition from autos to AI is becoming more obvious now'
-
Goldman Sachs Reiterates Neutral Rating on Tesla (TSLA)
-
TD Cowen Reiterates Buy Rating on Tesla (TSLA)
-
SpaceX targets in-house GPUs as it warns investors of chip supply, costs
-
Intel lands Tesla as first major customer for 14A chip technology
-
Unionised Samsung workers to hold rally in South Korea as labour unrest grows
-
Musician D4vd's alleged teen victim died of 'multiple penetrating injuries'
-
RBC Capital stays Outperform on Tesla (TSLA): expecting shares to trade higher as margins beat expectations
-
Expert Matchmaker in Peninsula Report by CX Research Institute
-
Trading Day: Nasdaq hits new high
-
After-hours movers: TSLA, TXN, IBM, LRCX, LULU, NOW
-
Form 8-K Tesla, Inc. For: Apr 22
-
Tesla Releases First Quarter 2026 Financial Results
-
Tesla lifts 2026 spending plans by a quarter as Musk funds AI and robotic dreams
-
ClearPoint Neuro receives FDA clearance for surgical drill system
-
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
-
S&P, Nasdaq close at records on Iran ceasefire extension, earnings

